Anti-viral drug remdesivir reduces risk of hospitalization in high-risk COVID-19 patients by 87%

After four weeks, 5.3% of the remdesivir group were hospitalized compared to 0.7% of the placebo group, decreasing the risk of hospitalization by 87%, new results from a clinical trial found.

from Articles | Mail Online https://ift.tt/3CAzGmO